Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Drugs & Side Effects News Monitoring

Get by Email • RSS

Published on Jun 1, 2025

Woman who lost six stone on Mounjaro reveals the horrible side effects no one talks about

A woman in her twenties has lost six stone in just nine months thanks to weight loss jabs - but it wasn't without some very unpleasant side effects. Bethany Diana, from the UK, went from a size 18 to a size eight after starting on Mounjaro (tirzepatide …

Source: Daily Mail - Right-wing
Published on Jun 1, 2025

Doctors warn of a horrifying new side effect of taking fat jabs - with the elderly and frail especially at risk

By XANTHA LEATHAM EXECUTIVE SCIENCE EDITOR Published: 16:55 EDT, 1 June 2025 | Updated: 17:11 EDT, 1 June 2025 Weight-loss drugs could be linked to osteoporosis and increased risk of bone fractures, doctors have warned. The Royal Osteoporosis Society (ROS) …

Source: Daily Mail - Right-wing
Published on Jun 1, 2025

Urgent health warning as the terrifying side effects of Ozempic emerge

By MAX ALDRED FOR DAILY MAIL AUSTRALIA Published: 04:57 EDT, 1 June 2025 | Updated: 04:57 EDT, 1 June 2025 Dozens of Aussie weight loss drug injection patients have complained of symptoms consistent with drug-induced hepatitis, sparking a warning from …

Source: Daily Mail - Right-wing
Published on Jun 1, 2025

I’ve lost 3.8 stone on Mounjaro but have had horrid side effects – hair loss & the ‘burning sensation’ is just the start

A YOUNG woman has revealed that thanks to Mounjaro, she was able to drop down from over 14 stone to just 10 stone in 28 weeks. But despite shifting the weight, Chloe Mckernan, 32, who is currently on her “glow up journey”, has experienced a number of …

Source: The Sun - Right-wing
Published on Jun 1, 2025

Exercise ‘better than drugs’ after treatment, international trial finds

Exercise can reduce the risk of cancer patients dying by a third, stop tumours coming back and is even more effective than drugs, according to the results of a landmark trial that could transform health guidelines worldwide. For decades, doctors have …

Source: The Guardian - Center-left
Published on Jun 1, 2025

'Liquid biopsies' alert advanced breast cancer patients when new drugs are needed

New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic breast cancer and help their tumors remain under control for more than a year. For many, it’s been a long time coming: More than a …

Source: NBC News - Center-left
Published on Jun 1, 2025

Woman sheds 4 stone(25 kilos) in 4 months on Mounjaro, then suffers liver failure—how the drug works and its risks

Aimee Chapman, 34, from Southampton, lost four stone in just four months using Mounjaro—but her rapid transformation came at a devastating cost. The former waitress was admitted to intensive care last summer with liver failure and a perforated oesophagus, …

Source: The Times of India - Center-right
Published on Jun 1, 2025

Which prescription weight loss pill is the strongest?

Liudmila Chernetska / iStockWhat Is the Strongest Weight Loss Prescription Pill? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Wondering what’s the strongest weight loss prescription pill? If you came here expecting a one-size-fits- …

Source: AOL - Pending
Published on Jun 1, 2025

Headlines — Ibot, Drug Therapy And Hurricane Aftermath

Circa 2005 DRUG THERAPY NEW DNA TEST IMPROVES RESULTS Through most of medical history, doctors have had to determine the correct dose of medication for an individual patient by trial and error. Because of genetic differences in the level of enzymes that …

Source: ABILITY Magazine - Neutral
Published on Jun 1, 2025

At ASCO, Merck KGaA Shows How Its Drug Measures Up as Treatment for Rare Type of Tumor

Patients with tenosynovial giant cell tumor can take some comfort in knowing that this rare type of tumor affecting joints won’t kill them. But that doesn’t make living with the disease easy. Merck KGaA has data from a pivotal study showing its once daily …

Source: MedCity News - Neutral
Published on Jun 1, 2025

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be …

Source: Regional Media News - Iowa - Pending
Published on Jun 1, 2025

Immunotherapy Drugs Show Major Progress in Early-Stage Cancer

(Bloomberg) -- Drugs that boost the body’s immune system to fight disease are showing promise in treating a variety of cancers in earlier stages, a development primed to expand their use and transform care for stubborn diseases like gastric and colon …

Source: Mint - Neutral
Published on Jun 1, 2025

Next-generation breast cancer drug targets tumours

Image by the US National Institutes of Health, CC 3.0 A powerful new drug for advanced breast cancer can be used to treat emerging resistance to treatment – months before tumours have a chance to grow. Results showed patients who were given the new therapy …

Source: Digital Journal - Neutral
Published on Jun 1, 2025

Mama June Ditches Weight Loss Drugs, Back To Old Ways?

Mama June Shannon has ditched her weight loss drugs, so does that mean she is back to her old ways? She gained a lot of weight when her daughter, Anna Cardwell, was sick. So, she wanted to get back on track, but is she done for good? Keep reading for more …

Source: TV Shows Ace - Neutral
Published on Jun 1, 2025

AstraZeneca buoyed by positive results for precision cancer drug

AstraZeneca has announced positive trial results for a breast cancer drug that can stop mutating tumours in their tracks and significantly improve survival chances. The late-stage trial of the camizestrant pill for “advanced” breast cancer cut the risk of …

Source: The Times - Center-right
Published on Jun 1, 2025

This anti-aging drug can extend the lifespan of mice by up to 30%

Scientists in Europe have discovered that a specific anti-aging drug mix can significantly extend the lifespan of mice while also improving their overall health. The combination involves two drugs, rapamycin and trametinib, both commonly used in cancer …

Source: BGR - New York - Pending
Published on Jun 1, 2025

AstraZeneca drug could help keep a common breast cancer at bay

Too often, cancer has a way of evading treatment. Tumors that were held in check begin to spread anew, forcing doctors to try different drugs in a desperate race to keep malignant cells from multiplying. For a common type of breast cancer, this usually …

Source: BioPharma Dive - Pending
Published on Jun 1, 2025

Switching to Experimental Drug Following Liquid Biopsy Detection of Breast Cancer Recurrence Enhances Patient Outcomes

A groundbreaking clinical trial has recently unveiled the transformative potential of liquid biopsy technology in the management of advanced breast cancer, specifically targeting treatment-resistant mutations to extend tumor control and enhance patient …

Source: Bioengineer.org - Pending
Published on Jun 1, 2025

Cancer drug which could 'double survival time' rolled out

ShareSave Gwen Buchan had been clear of breast cancer for more than a decade until her secondary diagnosis last year A drug which has been proven to extend the life of some people with incurable breast cancer has been given to patients on the NHS in Wales …

Source: BBC - Public Broadcaster

30 days 09:44:23

Featured Releases

Got News to Share? · Submit · See All

Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 12:48 GMT

ROSEN, LEADING INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before ...

NEW YORK, June 01, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of West Pharmaceutical Services, Inc. (NYSE: WST) between February 16, 2023 and February 12, 2025, both dates inclusive ( …

Distribution channels: Consumer Goods, Law ...

Published on June 1, 2025 - 22:30 GMT

Beyond the Table: How Sodium Chloride is Powering Emerging Green Industrial Processes Industries

The Sodium Chloride Market will grow at 4% CAGR from 2025 to 2035, reaching USD 70.99 Billion, driven by food, pharmaceuticals, and water treatment demand. NEWARK, DE, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- The sodium chloride market …

Distribution channels: Chemical Industry ...
Published on June 1, 2025 - 23:00 GMT

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in ...

– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on June 1, 2025 - 23:30 GMT

The Emerging Role of Sodium Lactate in Clean-Label Food Preservation and Its Ripple Effect on Industrial Demand Patterns

Sodium Lactate Market shifts from pharma to clean-label food, personal care, and eco-packaging, driven by demand for natural, multifunctional ingredients. NEWARK, DE, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- 𝐈𝐧𝐭𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧: 𝐀 𝐐𝐮𝐢𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫 𝐢𝐧 𝐚 …

Distribution channels: Chemical Industry ...
Published on May 28, 2025 - 18:00 GMT

BestRx Pharmacy Software Announces Integration with Lansworth Pharma SelfServe’s Pharmaself24 Kiosk Solution

BestRx is pleased to announce a new integration with Lansworth Pharma SelfServe, an advanced automated prescription pickup solution. OAKBROOK, IL, UNITED STATES, May 28, 2025 /⁨EINPresswire.com⁩/ -- BestRx, a RedSail Technologies company and a leading …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 30, 2025 - 12:48 GMT

Nasal Polyposis Drugs Market Size, Trends & Top Treatment Options 2025 | DataM Intelligence

The Global Nasal Polyposis Drugs Market is estimated to reach at a CAGR of 6.6% during the forecast period 2024-2031. AUSTIN, TX, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- Market Overview: The Global Nasal Polyposis Drugs Market is expanding …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 11:07 GMT

URGN CLASS ACTION NOTICE: UroGen Pharma Ltd. has been Sued for Securities Fraud after Stock Plummets 45% – Contact BFA ...

NEW YORK, May 31, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the Company’s senior executives for potential violations …

Distribution channels: Consumer Goods, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 818,131,516 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 1, 2025 - 23:16 GMT

Luis M. Gallardo Launches the Meta Pets Method, A Playful Path to Transformation for Therapists, Coaches, and Educators

A Card-Based System for Self-Inquiry, Healing, and Awakening in Education, Coaching, and Therapy. MIAMI, FL, UNITED STATES, June 1, 2025 /⁨EINPresswire.com⁩/ -- Author, hypnotherapist, and global well-being advocate Luis Miguel Gallardo announces …

Distribution channels: Book Publishing Industry, Business & Economy ...
Published on June 1, 2025 - 23:00 GMT

Impelsys Strengthens AI Transformation Strategy with AlgoShack Partnership

NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Impelsys, a global leader in technology solutions, is pleased to announce its strategic partnership with AlgoShack, a company that offers algoQA—a unified platform for end-to-end …

Distribution channels: Book Publishing Industry, Education ...
Published on June 1, 2025 - 23:30 GMT

Nxera Pharma Achieves Development Milestone in Collaboration with Eli Lilly Targeting Metabolic Diseases

Tokyo, Japan and Cambridge, UK, 2 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Company (“ …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:26 GMT

TORRAS Personal Cooling with Coolify Series: A Tech-Driven Solution for Comfort, Wellness, and Women's Health

LOS ANGELES, June 01, 2025 (GLOBE NEWSWIRE) -- As global temperatures continue to rise and daily comfort becomes a growing concern, TORRAS is making waves with its innovative Coolify series—a wearable air conditioner engineered to deliver rapid, personal …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 1, 2025 - 23:00 GMT

Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in ...

– New Drug Application based on positive results from the Phase 2 KOMET-001 trial – – FDA assigns a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2025 – – Potential first approval of a menin inhibitor for the treatment of adult …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 05:21 GMT

Smile Scarsdale Family Dental Celebrates One Year of Smiles as Trusted Family Dentist in Scarsdale

SCARSDALE, NY, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- Smile Scarsdale Family Dental is proud to celebrate its one-year anniversary of delivering exceptional family dental care to the Scarsdale community and surrounding areas. Since …

Distribution channels: Culture, Society & Lifestyle, Emergency Services ...
Published on June 1, 2025 - 17:12 GMT

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/...

Median DOR of 21.7 months with 80% of responders achieving a deep response (≥80% tumor shrinkage) Depth and durability translating to prolonged OS with median OS of 21.3 months and 2-year OS of 46% in HPV-negative HNSCC Conference call and webcast today at …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:45 GMT

Allogene Therapeutics Provides Updated Phase 1 Data Highlighting Durable Responses with ALLO-316 in Heavily Pretreated ...

Data Highlights Transformative Promise of CAR T in Solid Tumors Phase 1 Trial with ALLO-316 Demonstrated Potential to Provide Meaningful Clinical Benefit in Patients with CD70 TPS ≥ 50% Advanced or Metastatic RCC A Single Dose of ALLO-316 Achieved a 31% …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 14:00 GMT

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 ...

- RP1 plus nivolumab generated robust responses in both injected and non-injected lesions - - Deep/visceral injections, including into the liver and lung, resulted in numerically higher rates of response compared to superficial injections only and were …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
Published on June 1, 2025 - 00:41 GMT

Planet TV Studios Presents New Frontiers Episode 'Highlighting Emerging Technologies' Featuring Athena Clinic & Dr. ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON,, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 1, 2025 - 00:35 GMT

Planet TV Studios Presents New Frontiers: Innovators Shaping Tomorrow. The content in the episode is a Planet TV Studios ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 1, 2025 - 00:33 GMT

'New Frontiers' Presents 4 Companies Revolutionizing: Brian Cancer Therapies, Robotic Surgery, Sustainable Solutions & ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 1, 2025 - 00:29 GMT

"New Frontiers" Presents Featuring Athena Clinic, MonDak Portables, LLC, NeOnc Technologies Holdings, Inc. & Hollobus ...

Planet TV Studios proudly serves as the exclusive sponsor of the New Frontiers series. New Frontiers: "Highlighting Emerging Technologies" will air May 31st 2025 on Bloomberg Television at 5:00 pm ET. BOCA RATON, FL, UNITED STATES, May 31, 2025 …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 1, 2025 - 11:00 GMT

Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-...

First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making large- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 15:15 GMT

San Francisco Dental Implant Center Announces New Content on Convenient Dental Implant Locations in SF

San Francisco Dental Implant Center, a top dental implant center in San Francisco, California, is proud to announce new content focusing on convenient location. SAN FRANCISCO, CA, UNITED STATES, May 31, 2025 /⁨EINPresswire.com⁩/ -- San Francisco …

Distribution channels: Building & Construction Industry, Consumer Goods ...
Published on May 31, 2025 - 12:04 GMT

Libtayo® (cemiplimab) Phase 3 Data in the Adjuvant Treatment of Post-Surgical High-Risk Cutaneous Squamous Cell ...

Libtayo demonstrated a 68% reduction in the risk of disease recurrence or death, the primary endpoint of the trial (p<0.0001) Libtayo also demonstrated 80% and 65% reductions in the risk of locoregional and distant recurrence, respectively, compared to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on May 31, 2025 - 12:00 GMT

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/...

Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with an estrogen receptor 1 mutation Vepdegestrant was …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on May 31, 2025 - 00:00 GMT

The Good Feet Store Opens in Seabrook, NH to Help Local Residents and Workforce Live the Life They Love

The Leading Retailer of Premium, Personally-Fitted Arch Supports Expands with the Tenth Store in the Boston Area SEABROOK, NH, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- The Good Feet Store, recognized nationally as the market-leading …

Distribution channels: Companies, Consumer Goods ...
Published on May 31, 2025 - 00:00 GMT

Nurses for Natural Health Hosts Transformative Yoga Retreat for Nurses in France

PHOENIX , AZ, UNITED STATES, May 30, 2025 /⁨EINPresswire.com⁩/ -- This July, Nurses for Natural Health invites nurses from around the world to join a one-of-a-kind restorative yoga retreat in the picturesque town of Luz-Saint-Sauveur. Designed to …

Distribution channels: Education, Healthcare & Pharmaceuticals Industry ...
Published on May 31, 2025 - 12:00 GMT

Une analyse « Late Breaking » démontre les caractéristiques associées à la survie globale à long terme des patients avec ...

L’essai de Phase III NAPOLI 3 est la plus grande étude interventionnelle réalisée à ce jour avec la plus longue période de suivi des patients avec un adénocarcinome pancréatique métastatique1. L’analyse post-hoc de l’étude NAPOLI 3 a permis de déterminer …

Distribution channels: Healthcare & Pharmaceuticals Industry ...